205 related articles for article (PubMed ID: 1997493)
1. Effects of percent thresholding on the extraction of [18F]fluorodeoxyglucose positron emission tomographic region-of-interest data.
Rottenberg DA; Moeller JR; Strother SC; Dhawan V; Sergi ML
J Cereb Blood Flow Metab; 1991 Mar; 11(2):A83-8. PubMed ID: 1997493
[TBL] [Abstract][Full Text] [Related]
2. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
Schmidt KC; Lucignani G; Sokoloff L
J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
[No Abstract] [Full Text] [Related]
3. Methodologic factors affecting PET measurements of cerebral glucose metabolism.
Jagust WJ; Budinger TF; Huesman RH; Friedland RP; Mazoyer BM; Knittel BL
J Nucl Med; 1986 Aug; 27(8):1358-61. PubMed ID: 3488379
[TBL] [Abstract][Full Text] [Related]
4. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
[TBL] [Abstract][Full Text] [Related]
5. Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogeneous tissues: theoretical considerations and practical procedure.
Lucignani G; Schmidt KC; Moresco RM; Striano G; Colombo F; Sokoloff L; Fazio F
J Nucl Med; 1993 Mar; 34(3):360-9. PubMed ID: 8441024
[TBL] [Abstract][Full Text] [Related]
6. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
Arahata Y; Kato T; Tadokoro M; Sobue G
Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
[TBL] [Abstract][Full Text] [Related]
7. Peptide T and glucose metabolism in AIDS dementia complex.
Villemagne VL; Phillips RL; Liu X; Gilson SF; Dannals RF; Wong DF; Harris PJ; Ruff M; Pert C; Bridge P; London ED
J Nucl Med; 1996 Jul; 37(7):1177-80. PubMed ID: 8965193
[TBL] [Abstract][Full Text] [Related]
8. Dynamic [18F]fluorodeoxyglucose positron emission tomography and hypometabolic zones in seizures: reduced capillary influx.
Cornford EM; Gee MN; Swartz BE; Mandelkern MA; Blahd WH; Landaw EM; Delgado-Escueta AV
Ann Neurol; 1998 Jun; 43(6):801-8. PubMed ID: 9629850
[TBL] [Abstract][Full Text] [Related]
9. A regional covariance approach to the analysis of functional patterns in positron emission tomographic data.
Moeller JR; Strother SC
J Cereb Blood Flow Metab; 1991 Mar; 11(2):A121-35. PubMed ID: 1997480
[TBL] [Abstract][Full Text] [Related]
10. The metabolic pathology of the AIDS dementia complex.
Rottenberg DA; Moeller JR; Strother SC; Sidtis JJ; Navia BA; Dhawan V; Ginos JZ; Price RW
Ann Neurol; 1987 Dec; 22(6):700-6. PubMed ID: 3501695
[TBL] [Abstract][Full Text] [Related]
11. Effect of gender on glucose utilization rates in healthy humans: a positron emission tomography study.
Miura SA; Schapiro MB; Grady CL; Kumar A; Salerno JA; Kozachuk WE; Wagner E; Rapoport SI; Horwitz B
J Neurosci Res; 1990 Dec; 27(4):500-4. PubMed ID: 2079712
[TBL] [Abstract][Full Text] [Related]
12. [Tomographic measurement of human cerebral glucose metabolism].
Iwasaki Y; Konishi J; Makada Y; Yonekura Y
Nihon Rinsho; 1991 Jul; 49(7):1528-31. PubMed ID: 1886247
[No Abstract] [Full Text] [Related]
13. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle.
Martinez ZA; Colgan M; Baxter LR; Quintana J; Siegel S; Chatziioannou A; Cherry SR; Mazziotta JC; Phelps ME
Am J Primatol; 1997; 42(3):215-24. PubMed ID: 9209586
[TBL] [Abstract][Full Text] [Related]
14. Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data.
Dhawan V; Moeller JR; Strother SC; Evans AC; Rottenberg DA
J Nucl Med; 1989 Sep; 30(9):1483-8. PubMed ID: 2788721
[TBL] [Abstract][Full Text] [Related]
15. PET studies of cerebral glucose metabolism in conscious rhesus macaques.
Eberling JL; Roberts JA; De Manincor DJ; Brennan KM; Hanrahan SM; Vanbrocklin HF; Roos MS; Jagust WJ
Neurobiol Aging; 1995; 16(5):825-32. PubMed ID: 8532117
[TBL] [Abstract][Full Text] [Related]
16. The metabolic topography of normal aging.
Moeller JR; Ishikawa T; Dhawan V; Spetsieris P; Mandel F; Alexander GE; Grady C; Pietrini P; Eidelberg D
J Cereb Blood Flow Metab; 1996 May; 16(3):385-98. PubMed ID: 8621743
[TBL] [Abstract][Full Text] [Related]
17. Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study.
Brunetti A; Berg G; Di Chiro G; Cohen RM; Yarchoan R; Pizzo PA; Broder S; Eddy J; Fulham MJ; Finn RD
J Nucl Med; 1989 May; 30(5):581-90. PubMed ID: 2785582
[TBL] [Abstract][Full Text] [Related]
18. Age differences in intercorrelations between regional cerebral metabolic rates for glucose.
Horwitz B; Duara R; Rapoport SI
Ann Neurol; 1986 Jan; 19(1):60-7. PubMed ID: 3484930
[TBL] [Abstract][Full Text] [Related]
19. [Cerebral glucose metabolism in dementia (PET-FDG study)].
Hatazawa J; Itoh M; Matsuzawa T
Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
[TBL] [Abstract][Full Text] [Related]
20. Simplified calculation of MRglc using PET.
Phillips RL; London ED
J Nucl Med; 1997 Aug; 38(8):1334. PubMed ID: 9255178
[No Abstract] [Full Text] [Related]
[Next] [New Search]
